Homebiotech

biotech

biotech

Thalassaemia treatment gets EU approval

Jim Cornall - May 27, 2026

biotech

New data from Parkinson’s disease trial

Jim Cornall - May 27, 2026

biotech

Restoring the “longevity protein”

Jim Cornall - May 27, 2026

biotech

Positive topline results from phase 2 recurrent ovarian cancer trial

Jim Cornall - May 26, 2026

biotech

Promise for early Parkinson’s detection analysis

Jim Cornall - October 28, 2025

biotech

More funds for prosthetic joint infection treatment

Jim Cornall - October 27, 2025

biotech

$22.4m raised for respiratory infections nasal spray

Jim Cornall - October 27, 2025

biotech

Reduced risk of prostate cancer death with drug combo

Jim Cornall - October 27, 2025

biotech

Base to Base biotech podcast 32: Multi-omics data and protein degradation

Jim Cornall - October 24, 2025

biotech

Genetic discovery offers hope for personalised prevention of cardiovascular disease

Jim Cornall - October 23, 2025

biotech

Positive results from Pfizer breast cancer trial

Jim Cornall - October 23, 2025

biotech

CN Bio launches all-in-one organ-on-a-chip system

Jim Cornall - October 23, 2025

1...454647...79 Page 46 of 79

Stay Connected

- Advertisement -

spot_img

Latest Articles

biotech

Thalassaemia treatment gets EU approval

Jim Cornall - May 27, 2026 0

Agios Pharmaceuticals, Inc. has revealed that the European Commission has granted marketing authorisation for PYRUKYND (mitapivat), an oral pyruvate kinase (PK) activator, in adults...

New data from Parkinson’s disease trial

biotech Jim Cornall - May 27, 2026 0

Restoring the “longevity protein”

biotech Jim Cornall - May 27, 2026 0

Positive topline results from phase 2 recurrent ovarian cancer trial

biotech Jim Cornall - May 26, 2026 0

Rare oral cancer has distinct genetic profile

biotech Jim Cornall - May 26, 2026 0